Iron, hepatitis C virus, and hepatocellular carcinoma: Iron reduction preaches the gospel for chronic hepatitis C

Journal of Gastroenterology

Volumn 42, Issue 11, 2007, Pages 923-926

  Fujita, Naoki ^a   Takei, Yoshiyuki ^a  

^a MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; DNA; FERRITIN; INTERFERON; IRON; POLYPROTEIN; TRANSFERRIN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; CANCER RISK; CHRONIC HEPATITIS; CLINICAL TRIAL; DNA DAMAGE; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IRON BLOOD LEVEL; IRON OVERLOAD; IRON RESTRICTION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NONHUMAN; OXIDATIVE STRESS; PHLEBOTOMY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE;

CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IRON; IRON, DIETARY; PHLEBOTOMY; RISK FACTORS;

EID: 36348932285     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-007-2110-4     Document Type: Editorial

References (44)

1. LB Seeff 2002 Natural history of chronic hepatitis C Hepatology 36 Suppl 1 35-46 10.1002/hep.1840360706
2. Hepatitis viruses 1994 IARC monographs on the evaluation of the carcinogenic risks of humans International Agency for Research on Cancer Lyon, France
3. D Sakamuro T Furukawa T Takegami 1995 Hepatitis C nonstructural protein NS3 transforms NIH 3T3 cells J Virol 69 3893-6 7745741 1:CAS:528:DyaK2MXls1yhsrk%3D
4. RB Ray LM Lagging K Meyer R Ray 1996 Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype J Virol 70 4438-43 8676467 1:CAS:528:DyaK28XjsFygsrc%3D
5. K Moriya H Fujie Y Shintani H Yotsuyanagi T Tsutsumi K Ishibashi 1998 The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice Nat Med 4 1065-7 9734402 10.1038/2053 1:CAS:528:DyaK1cXlvFGns7o%3D
6. H Toyoda T Kumada A Tokuda Y Horiguchi H Nakano T Honda 2000 Long-term follow-up of sustained responders to interferon therapy in patients with chronic hepatitis C J Viral Hepat 7 414-9 11115052 10.1046/ j.1365-2893.2000.00241.x 1:STN:280:DC%2BD3M3it1Oqtw%3D%3D
7. MW Hentze MU Muckenthaler NC Andrews 2004 Balancing acts: Molecular control of mammalian iron metabolism Cell 117 285-97 15109490 10.1016/ S0092-8674(04)00343-5 1:CAS:528:DC%2BD2cXjvFemsbg%3D
8. N De Maria A Colantoni S Fagiuoli GJ Liu BK Rogers F Farinati 1996 Association between reactive oxygen species and disease activity in chronic hepatitis C Free Radic Biol Med 21 291-5 8855439 10.1016/ 0891-5849(96)00044-5 1:CAS:528:DyaK28XltFKisL0%3D
9. AM Di Bisceglie CA Axiotis JH Hoofnagle BR Bacon 1992 Measurements of iron status in patients with chronic hepatitis Gastroenterology 102 2108-13 1587431 1:STN:280:By2B28jjtFI%3D
10. S Haque B Chandra MA Gerber ASF Lok 1996 Iron overload in patients with chronic hepatitis C: A clinicopathologic study Hum Pathol 27 1277-81 8958298 10.1016/S0046-8177(96)90337-8 1:STN:280:ByiC3Mjit10%3D
11. Fujita N, Sugimoto R, Urawa N, Araki J, Mifuji R, Yamamoto M, et al. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C. J Gastroenterol Hepatol 2007 (in press)
12. T Isomura M Yano H Hayashi N Sakamoto 1992 Excess iron in the liver of patients with chronic hepatitis C J Clin Electron Microsc 25 231-7
13. R Shimoda M Nagashima M Sakamoto N Yamaguchi S Hirohashi J Yokota 1994 Increased formation of oxidative DNA damage, 8-hydroxydeoxyguanosine, in human livers with chronic hepatitis Cancer Res 54 3171-2 8205535 1:STN:280:ByuB28rhs1Y%3D
14. V Paradis P Mathurin M Kollinger F Imbert-Bismut F Charlotte A Piton 1997 In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features J Clin Pathol 50 401-6 9215123 10.1136/jcp.50.5.401 1:STN:280:ByiA2MjpsVY%3D
15. E Larrea O Beloqui MA Munoz-Navas MP Civeira J Prieto 1998 Superoxide dismutase in patients with chronic hepatitis C virus infection Free Radic Biol Med 24 1235-41 9626579 10.1016/S0891-5849(97)00437-1 1:CAS:528:DyaK1cXjsFWhtrk%3D
16. S Horiike S Kawanishi M Kaito M Ning H Tanaka N Fujita 2005 Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C J Hepatol 43 403-10 16023246 10.1016/j.jhep.2005.03.026 1:CAS:528:DC%2BD2MXntVCkurg%3D
17. Y Sumida T Nakashima T Yoh Y Kakisaka Y Nakajima H Ishikawa 2001 Serum thioredoxin elucidates the significance of serum ferritin as a marker of oxidative stress in chronic liver diseases Liver 21 295-9 11589765 10.1034/j.1600-0676.2001.210501.x 1:CAS:528:DC%2BD3MXns1yktbg%3D
18. S Shibutani M Takeshita AP Grollman 1991 Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxoG Nature 349 431-4 1992344 10.1038/349431a0 1:CAS:528:DyaK3MXhsF2htL4%3D
19. N Fujita S Horiike R Sugimoto H Tanaka M Iwasa Y Kobayashi 2007 Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C Free Radic Biol Med 42 353-62 17210448 10.1016/ j.freeradbiomed.2006.11.001 1:CAS:528:DC%2BD2sXis1ehtA%3D%3D
20. C Puoti A Magrini T Stati P Rigato F Montagnese P Rossi 1997 Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels Hepatology 26 1393-8 9397976 10.1002/hep.510260603 1:STN:280:DyaK1c%2FlvVGrtw%3D%3D
21. T Okanoue A Makiyama M Nakayama Y Sumida H Mitsuyoshi T Nakajima 2005 A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase J Hepatol 43 599-605 16024129 10.1016/ j.jhep.2005.04.008
22. M Sartori S Andorno C Rigamonti E Grossini G Nicosia R Boldorini 2000 Chronic hepatitis C is mild in menstruating women J Gastroenterol Hepatol 15 1411-7 11197052 10.1046/j.1440-1746.2000.02368.x 1:STN:280:DC%2BD3M7jvFChtg%3D%3D
23. H Hayashi T Takikawa N Nishimura M Yano T Isomura N Sakamoto 1994 Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron Am J Gastroenterol 89 986-8 8017395 1:STN:280:ByuB1cfgtF0%3D
24. H Hayashi T Takikawa N Nishimura M Yano 1995 Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C J Hepatol 22 268-71 7608476 10.1016/0168-8278(95)80278-9 1:STN:280:ByqA3s3msV0%3D
25. HL Bonkovsky 1997 Therapy of hepatitis C: Other options Hepatology 26 Suppl 1 143-51 10.1002/hep.510260725
26. M Yano H Hayashi S Wakusawa F Sanae T Takikawa Y Shiono 2002 Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C Am J Gastroenterol 97 133-7 11808937 10.1111/ j.1572-0241.2002.05436.x 1:CAS:528:DC%2BD38XhtlamtLk%3D
27. M Yano H Hayashi K Yoshioka Y Kohgo H Saito Y Niitsu 2004 A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C: A multicenter, prospective, randomized, controlled trial in Japan J Gastroenterol 39 570-4 15235875 10.1007/s00535-003-1344-z 1:CAS:528:DC%2BD2cXlt1ylsLk%3D
28. M Iwasa M Kaito J Ikoma Y Kobayashi Y Tanaka K Higuchi 2002 Dietary iron restriction improves aminotransferase levels in chronic hepatitis C patients Hepatogastroenterology 49 529-31 11995488 1:CAS:528:DC%2BD38XjslKhsrk%3D
29. YM Kowdley 2004 Iron hemochromatosis, and hepatocellular carcinoma Gastroenterology 127 Suppl 3 79-86 10.1016/j.gastro.2004.09.019
30. E Mandishona AP MacPhail VR Gordeuk MA Kedda AC Paterson TA Rouault 1998 Dietary iron overload as a risk factor for hepatocellular carcinoma in black Africans Hepatology 27 1563-6 9620327 10.1002/hep.510270614 1:STN:280:DyaK1c3otFKgtQ%3D%3D
31. C Borgna-Pignatti G Vergine T Lombardo MD Cappellini P Cianciulli A Maggio 2004 Hepatocellular carcinoma in the thalassaemia syndromes Br J Haematol 124 114-7 14675416 10.1046/j.1365-2141.2003.04732.x
32. T Furutani K Hino M Okuda T Gondo S Nishina A Kitase 2006 Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein Gastroenterology 130 2087-98 16762631 10.1053/j.gastro.2006.02.060 1:CAS:528:DC%2BD28XntVWit78%3D
33. K Moriya K Nakagawa T Santa Y Shintani H Fujie H Miyoshi 2001 Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis Cancer Res 61 4365-70 11389061 1:CAS:528:DC%2BD3MXktlSqu7o%3D
34. G Gong G Waris R Tanveer A Siddiqui 2001 Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress and activates STAT-3 and NK-kappa B Proc Natl Acad Sci USA 98 9599-604 11481452 10.1073/pnas.171311298 1:CAS:528:DC%2BD3MXmtlCnur0%3D
35. M Okuda K Li MR Beard LA Showalter F Scholle SM Lemon 2002 Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein Gastroenterology 122 366-75 11832451 10.1053/gast.2002.30983 1:CAS:528:DC%2BD38XhsVGns7o%3D
36. J Kato K Miyanishi M Kobune T Nakamura K Takada R Takimoto 2007 Long-term phlebotomy with low-iron diet therapy lowers risk of development of hepatocellular carcinoma from chronic hepatitis C J Gastroenterol 42 830-6 17940836 10.1007/s00535-007-2095-z 1:CAS:528:DC%2BD2sXhtFyrur3J
37. J Kato M Kobune T Nakamura G Kuroiwa K Takada R Takimoto 2001 Normalization of elevated hepatic 8-hydroxy-2′-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet Cancer Res 61 8697-702 11751387 1:CAS:528:DC%2BD38Xht1Ogug%3D%3D
38. K Kiyosawa E Tanaka 2002 Characteristics of hepatocellular carcinoma in Japan Oncology 62 Suppl 1 5-7 11868786 10.1159/000048269
39. HB El-Serag 2002 Hepatocellular carcinoma and hepatitis C in the united status Hepatology 36 Suppl 1 74-83 10.1002/hep.1840360710
40. N Tanaka H Akira T Yamaura M Komatsu E Tanaka K Kiyosawa 2007 Efficacy and safety of 6-month iron reduction therapy in patients with hepatitis C virus-related cirrhosis: A pilot study J Gastroenterol 42 49-55 17322993 10.1007/s00535-006-1967-y 1:CAS:528:DC%2BD2sXitVOltL4%3D
41. K Iwata M Iwasa N Hara A Matsumoto Y Kobayashi S Watanabe 2006 Iron content and consumption of health foods by patients with chronic hepatitis C J Gastroenterol 41 919-20 17048058 10.1007/s00535-006-1860-8
42. DM Frazer GJ Anderson 2003 The orchestration of body iron intake: How and where do enterocytes receive their cues? Blood Cells Mol Dis 30 288-97 12737947 10.1016/S1079-9796(03)00039-1 1:CAS:528:DC%2BD3sXjsVGmtrs%3D
43. E Nemeth MS Tuttle J Powelson MB Vaughn A Donovan DM Ward 2004 Hepcidin regulates iron efflux by binding to ferroportin and inducing its internalization Science 306 2090-3 15514116 10.1126/science.1104742 1:CAS:528:DC%2BD2cXhtVOjsL3K
44. N Fujita R Sugimoto M Takeo N Urawa R Mifuji H Tanaka 2007 Hepcidin expression in the liver: Relatively low level in patients with chronic hepatitis C Mol Med 13 97-104 17515961 1:CAS:528:DC%2BD2sXmt12rsb4%3D